Kalaris Therapeutics, Inc. (KLRS)
Nasdaq: KLRS · Biological Products, (No Diagnostic Substances) · Berkeley Heights, NJ · filing with the SEC since 2018
Who runs Kalaris Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Hallal David
Chief Executive Officer. First filing Jul 2020, latest Jun 4, 2026, 7 filings in all.
Officers reporting now
7
of 14 people with a filing in the last fifteen months
Directors reporting now
7
38 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Vandekop Amy O'Leary | VP, Corporate Controller | Jul 2026 | Aug 28, 2026 | none |
| Bayko Liisa Ann | Chief Financial Officer | Jul 2026 | Jul 20, 2026 | none |
| Hallal David | Chief Executive Officer | Jul 2020 | Jun 4, 2026 | none |
| Hagen Brett R | Chief Accounting Officer | Jul 2020 | Mar 23, 2026 | 1 · $0.00 |
| Oxtoby Andrew | President and Chief Executive Officer | Mar 2025 | Mar 20, 2026 | none |
| Gall Matthew | Chief Financial Officer | Nov 2025 | Mar 20, 2026 | none |
| Feinsod Matthew | Chief Medical Officer | Mar 2025 | Mar 20, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Keating Laurie | director | Aug 2026 | Aug 3, 2026 | none |
| Adamis Anthony P | director | Mar 2025 | Jun 4, 2026 | none |
| Akkaraju Srinivas | director | Mar 2025 | Jun 4, 2026 | none |
| Dybbs Michael | director | Mar 2025 | Jun 4, 2026 | none |
| Ferrara Napoleone | director | Mar 2025 | Jun 4, 2026 | none |
| Jovan-Embiricos Morana | director | Jul 2020 | Jun 4, 2026 | none |
| Patterson Leone D | director | Apr 2025 | Jun 4, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Samsara Biocapital Gp, LLC | 10% owner | Mar 2025 | May 22, 2026 | none |
| Samsara Biocapital, L.P. | 10% owner | Mar 2025 | May 22, 2026 | none |
| Samsara Opportunity Fund Gp, LLC | 10% owner | Dec 2025 | May 22, 2026 | none |
| Samsara Opportunity Fund, L.P. | 10% owner | Dec 2025 | May 22, 2026 | none |
Earlier names on the record27, newest filing first
Patel Samir Chandrakant · director · last filing Apr 2025Sinha Vikas · officer · last filing Feb 2025Miller Edward · officer · last filing Feb 2025Brainard Diana · officer · last filing Nov 2024Adams Derek N. · director · last filing Jun 2024Bornstein Jeffrey S · director · last filing Jun 2024Brenner Malcolm · director · last filing Jun 2024Tomasello Shawn · director · last filing Jun 2024Vera Juan · director · last filing Jun 2024Piccina Cintia · officer · last filing Jul 2023Gilead Sciences, Inc. · 10% owner · last filing Jun 2023Leen Ann M. · officer · last filing Feb 2023Van Beek Jeroen B · officer · last filing Nov 2022Atillasoy Ercem · officer · last filing Oct 2022F2 - Tpo Investments LLC · director · last filing Aug 2022F2 Bioscience Av 2022 LLC · director · last filing Aug 2022F2 Capital I 2020 · director · last filing Aug 2022F2 Mc, LLC · director · last filing Aug 2022F2 Mg Ltd · director · last filing Aug 2022Globeways Holdings II Ltd · director · last filing Aug 2022Globeways Holdings Ltd · director · last filing Aug 2022Elevatebio, LLC · director · last filing Aug 2022Gadicke Ansbert · director · last filing Aug 2022Melian Agustin · officer · last filing Oct 2021Wilson John Robert · director · last filing May 2021Green Jeremy · 10% owner · last filing Aug 2020Redmile Group, LLC · 10% owner · last filing Aug 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.